Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a type of autoimmune encephalitis characterized by seizures, psychiatric symptoms, and movement disorder, which may present with an acute or subacute course. It has been reported that the production of anti-NDMA receptor antibodies can be triggered in the course of herpes simplex encephalitis and anti-NMDA receptor encephalitis may occur clinically. It has been reported that 25% of patients with HSV encephalitis have anti-NDMA receptor antibodies and are associated with impaired improvement in cognitive performance. In this article, we present a case of anti-NMDA receptor encephalitis associated with HSV-type 1 encephalitis in a 30-year-old woman and review the literature. After the patient's treatment for HSV encephalitis ended, her psychiatric symptoms such as anxiety, agitation, hallucinations and euphoria persisted and he was diagnosed with anti NMDA receptor antibodies detected in CSF. The patient was transferred to the neurology clinic and intravenous immunoglobulin treatment was started.
Anti-N-metil-D-aspartat (NDMA) reseptör ensefaliti akut veya subakut seyir gösterebilen, nöbet, psikiyatrik semptomlar ve hareket bozukluğu ile karakterize otoimmun bir ensefalit türüdür. Herpes simpleks ensefaliti seyrinde anti-NDMA reseptör antikorlarının üretiminin tetiklenebileceği ve anti-NMDA ensefalitinin klinik olarak ortaya çıkabileceği bildirilmiştir. HSV ensefalitli hastaların %25’inde anti-NDMA reseptör antikorlarının ortaya çıktığı ve bilinçsel performasdaki iyileşmede bozulma ile ilişkili.olduğu rapor edilmiştir. Bu yazıda 30 yaşında kadın hastada HSV-tip 1 ensefaliti ile birlikte saptanan anti NMDA reseptör ensefaliti olgusu sunularak literatür gözden geçirildi. Hastanın HSV ensefalitine yönelik tedavisi bittikten sonra anksiyete, ajitasyon, halüsünasyon ve öfori gibi psikiyatrik semptomlarının devam etmesi üzerine BOS’da bakılan anti-NMDA reseptör antikorlarının pozitif saptanması ile tanı konuldu. Nöroloji kliniğine devredilen hastaya intravenöz immunglobulin tedavisi başlandı.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Case Report |
Authors | |
Publication Date | September 23, 2020 |
Published in Issue | Year 2020 Volume: 2 Issue: 4 |
Interuniversity Board (UAK) Equivalency: 1b [Original research article published in journals scanned by international field indexes (included in indices other than the ones mentioned in 1a) - 10 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Journal is indexed in;
Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), General Impact Factor, OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, Turk Medline.
Ulakbim-TR Dizin, Index Copernicus, EBSCO, DOAJ is under evaluation.
Journal articles are evaluated as "Double-Blind Peer Review"
.
There is no charge for sending articles, submitting, evaluating and publishing.
Assoc Prof Dr Muhammed KIZILGÜL was qualified as an Associated Editor in ACMJ on 15/02/2020,
Assoc. Prof. Dr. Ercan YUVANÇ leaved, Assoc. Prof. Dr. Alpaslan TANOĞLU became the Editör in Chief in ACMJ on 13/05/2020.